Phase I Study of CS-7017 and Bexarotene

NCT01504490 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Drug no longer available

Conditions

Solid Tumors
Lymphoma
Multiple Myeloma

Interventions

DRUG: CS-7017 and Bexarotene

Sponsor

Georgetown University

Collaborators

[object Object]